First-in-human Study to Investigate the Safety, Tolerability and Blood Levels of the Test Drug MP0250 in Cancer Patients
Clinical trial NCT02194426 · COMPLETED
Trial details
- NCT number
- NCT02194426
- Sponsor
- Molecular Partners AG
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2018-02-20
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.